Evaluation  ||| S:0 E:11 ||| NN
of  ||| S:11 E:14 ||| IN
a  ||| S:14 E:16 ||| DT
mask  ||| S:16 E:21 ||| NN
for  ||| S:21 E:25 ||| IN
breath-by-breath  ||| S:25 E:42 ||| JJ
respirometry  ||| S:42 E:55 ||| NN
during  ||| S:55 E:62 ||| IN
exercise  ||| S:62 E:71 ||| NN
in  ||| S:71 E:74 ||| IN
horses  ||| S:74 E:81 ||| NNS
The  ||| S:81 E:85 ||| DT
ability  ||| S:85 E:93 ||| NN
to  ||| S:93 E:96 ||| TO
obtain  ||| S:96 E:103 ||| VB
breath-by-breath  ||| S:103 E:120 ||| JJ
measures  ||| S:120 E:129 ||| NNS
of  ||| S:129 E:132 ||| IN
ventilatory  ||| S:132 E:144 ||| JJ
mechanics  ||| S:144 E:154 ||| NNS
for  ||| S:154 E:158 ||| IN
the  ||| S:158 E:162 ||| DT
entirety  ||| S:162 E:171 ||| NN
of  ||| S:171 E:174 ||| IN
an  ||| S:174 E:177 ||| DT
exercise  ||| S:177 E:186 ||| NN
test ||| S:186 E:190 ||| NN
,  ||| S:190 E:192 ||| ,
regardless  ||| S:192 E:203 ||| RB
of  ||| S:203 E:206 ||| IN
speed ||| S:206 E:211 ||| NN
( ||| S:211 E:212 ||| -LRB-
s ||| S:212 E:213 ||| LS
)  ||| S:213 E:215 ||| -RRB-
or  ||| S:215 E:218 ||| CC
duration  ||| S:218 E:227 ||| NN
enables  ||| S:227 E:235 ||| VBZ
evaluations  ||| S:235 E:247 ||| VBN
of  ||| S:247 E:250 ||| IN
equine  ||| S:250 E:257 ||| JJ
ventilation  ||| S:257 E:269 ||| NN
during  ||| S:269 E:276 ||| IN
exercise  ||| S:276 E:285 ||| NN
that  ||| S:285 E:290 ||| WDT
are  ||| S:290 E:294 ||| VBP
necessary  ||| S:294 E:304 ||| JJ
for  ||| S:304 E:308 ||| IN
assessments  ||| S:308 E:320 ||| NNS
of  ||| S:320 E:323 ||| IN
performance ||| S:323 E:334 ||| NN
.  ||| S:334 E:336 ||| .
Evaluation  ||| S:336 E:347 ||| NN
of  ||| S:347 E:350 ||| IN
a  ||| S:350 E:352 ||| DT
new  ||| S:352 E:356 ||| JJ
ergospirometer  ||| S:356 E:371 ||| NNS
( ||| S:371 E:372 ||| -LRB-
Quadflow ||| S:372 E:380 ||| NNP
;  ||| S:380 E:382 ||| :
QF ||| S:382 E:384 ||| NNP
)  ||| S:384 E:386 ||| -RRB-
system ||| S:386 E:392 ||| NN
's  ||| S:392 E:395 ||| POS
accuracy  ||| S:395 E:404 ||| NN
and  ||| S:404 E:408 ||| CC
repeatability  ||| S:408 E:422 ||| NN
for  ||| S:422 E:426 ||| IN
measuring  ||| S:426 E:436 ||| VBG
pulmonary  ||| S:436 E:446 ||| JJ
variables  ||| S:446 E:456 ||| NNS
in  ||| S:456 E:459 ||| IN
contrast  ||| S:459 E:468 ||| NN
to  ||| S:468 E:471 ||| TO
the  ||| S:471 E:475 ||| DT
established  ||| S:475 E:487 ||| JJ
pneumotachometer-based  ||| S:487 E:510 ||| JJ
system  ||| S:510 E:517 ||| NN
( ||| S:517 E:518 ||| -LRB-
control ||| S:518 E:525 ||| NN
)  ||| S:525 E:527 ||| -RRB-
and  ||| S:527 E:531 ||| CC
assessment  ||| S:531 E:542 ||| NN
of  ||| S:542 E:545 ||| IN
its  ||| S:545 E:549 ||| PRP$
effects ||| S:549 E:556 ||| NNS
,  ||| S:556 E:558 ||| ,
if  ||| S:558 E:561 ||| IN
any ||| S:561 E:564 ||| DT
,  ||| S:564 E:566 ||| ,
on  ||| S:566 E:569 ||| IN
exercise  ||| S:569 E:578 ||| NN
capacity  ||| S:578 E:587 ||| NN
at  ||| S:587 E:590 ||| IN
high  ||| S:590 E:595 ||| JJ
speeds ||| S:595 E:601 ||| NNS
.  ||| S:601 E:603 ||| .
Five  ||| S:603 E:608 ||| CD
Thoroughbred  ||| S:608 E:621 ||| JJ
horses  ||| S:621 E:628 ||| NNS
each  ||| S:628 E:633 ||| DT
performed  ||| S:633 E:643 ||| VBN
10  ||| S:643 E:646 ||| CD
incremental  ||| S:646 E:658 ||| JJ
exercise  ||| S:658 E:667 ||| NN
tests  ||| S:667 E:673 ||| NNS
to  ||| S:673 E:676 ||| TO
fatigue ||| S:676 E:683 ||| VB
,  ||| S:683 E:685 ||| ,
5  ||| S:685 E:687 ||| CD
with  ||| S:687 E:692 ||| IN
the  ||| S:692 E:696 ||| DT
QF  ||| S:696 E:699 ||| NNP
system  ||| S:699 E:706 ||| NN
and  ||| S:706 E:710 ||| CC
5  ||| S:710 E:712 ||| CD
with  ||| S:712 E:717 ||| IN
an  ||| S:717 E:720 ||| DT
open-circuit  ||| S:720 E:733 ||| JJ
flow  ||| S:733 E:738 ||| NN
system ||| S:738 E:744 ||| NN
.  ||| S:744 E:746 ||| .
Measures  ||| S:746 E:755 ||| NNS
of  ||| S:755 E:758 ||| IN
pulmonary  ||| S:758 E:768 ||| JJ
variables  ||| S:768 E:778 ||| NNS
were  ||| S:778 E:783 ||| VBD
evaluated  ||| S:783 E:793 ||| VBN
to  ||| S:793 E:796 ||| TO
determine  ||| S:796 E:806 ||| VB
repeatability ||| S:806 E:819 ||| NNS
.  ||| S:819 E:821 ||| .
Heart  ||| S:821 E:827 ||| NN
rate ||| S:827 E:831 ||| NN
,  ||| S:831 E:833 ||| ,
pulmonary  ||| S:833 E:843 ||| JJ
variables ||| S:843 E:852 ||| NNS
,  ||| S:852 E:854 ||| ,
arterial  ||| S:854 E:863 ||| JJ
blood  ||| S:863 E:869 ||| NN
gases ||| S:869 E:874 ||| NNS
,  ||| S:874 E:876 ||| ,
distance  ||| S:876 E:885 ||| NN
run  ||| S:885 E:889 ||| NN
and  ||| S:889 E:893 ||| CC
time  ||| S:893 E:898 ||| NN
to  ||| S:898 E:901 ||| TO
fatigue  ||| S:901 E:909 ||| VB
measured  ||| S:909 E:918 ||| VBN
with  ||| S:918 E:923 ||| IN
each  ||| S:923 E:928 ||| DT
system  ||| S:928 E:935 ||| NN
were  ||| S:935 E:940 ||| VBD
compared  ||| S:940 E:949 ||| VBN
to  ||| S:949 E:952 ||| TO
assess  ||| S:952 E:959 ||| VB
similarity  ||| S:959 E:970 ||| NN
of  ||| S:970 E:973 ||| IN
results  ||| S:973 E:981 ||| NNS
and  ||| S:981 E:985 ||| CC
effect  ||| S:985 E:992 ||| NN
on  ||| S:992 E:995 ||| IN
performance ||| S:995 E:1006 ||| NN
.  ||| S:1006 E:1008 ||| .
Results  ||| S:1008 E:1016 ||| NNS
from  ||| S:1016 E:1021 ||| IN
both  ||| S:1021 E:1026 ||| DT
systems  ||| S:1026 E:1034 ||| NNS
had  ||| S:1034 E:1038 ||| VBD
high  ||| S:1038 E:1043 ||| JJ
repeatability  ||| S:1043 E:1057 ||| NN
with  ||| S:1057 E:1062 ||| IN
low  ||| S:1062 E:1066 ||| JJ
coefficients  ||| S:1066 E:1079 ||| NN
of  ||| S:1079 E:1082 ||| IN
variation ||| S:1082 E:1091 ||| NN
.  ||| S:1091 E:1093 ||| .
The  ||| S:1093 E:1097 ||| DT
QF  ||| S:1097 E:1100 ||| NNP
was  ||| S:1100 E:1104 ||| VBD
associated  ||| S:1104 E:1115 ||| VBN
with  ||| S:1115 E:1120 ||| IN
greater  ||| S:1120 E:1128 ||| JJR
resistance  ||| S:1128 E:1139 ||| NN
to  ||| S:1139 E:1142 ||| TO
airflow ||| S:1142 E:1149 ||| VB
,  ||| S:1149 E:1151 ||| ,
higher  ||| S:1151 E:1158 ||| JJR
breathing  ||| S:1158 E:1168 ||| NN
rate  ||| S:1168 E:1173 ||| NN
at  ||| S:1173 E:1176 ||| IN
submaximal  ||| S:1176 E:1187 ||| JJ
speeds ||| S:1187 E:1193 ||| NNS
,  ||| S:1193 E:1195 ||| ,
lower  ||| S:1195 E:1201 ||| JJR
minute  ||| S:1201 E:1208 ||| NN
ventilation  ||| S:1208 E:1220 ||| NN
and  ||| S:1220 E:1224 ||| CC
peak  ||| S:1224 E:1229 ||| JJ
inspiratory  ||| S:1229 E:1241 ||| NN
and  ||| S:1241 E:1245 ||| CC
expiratory  ||| S:1245 E:1256 ||| JJ
airflows ||| S:1256 E:1264 ||| NN
,  ||| S:1264 E:1266 ||| ,
greater  ||| S:1266 E:1274 ||| JJR
acidaemia ||| S:1274 E:1283 ||| NN
,  ||| S:1283 E:1285 ||| ,
hypoxaemia  ||| S:1285 E:1296 ||| NN
and  ||| S:1296 E:1300 ||| CC
hypercapnoea ||| S:1300 E:1312 ||| NN
,  ||| S:1312 E:1314 ||| ,
and  ||| S:1314 E:1318 ||| CC
decreased  ||| S:1318 E:1328 ||| VBD
total  ||| S:1328 E:1334 ||| JJ
run  ||| S:1334 E:1338 ||| NN
time  ||| S:1338 E:1343 ||| NN
and  ||| S:1343 E:1347 ||| CC
total  ||| S:1347 E:1353 ||| JJ
distance  ||| S:1353 E:1362 ||| NN
run  ||| S:1362 E:1366 ||| NN
when  ||| S:1366 E:1371 ||| WRB
compared  ||| S:1371 E:1380 ||| VBN
to  ||| S:1380 E:1383 ||| TO
control  ||| S:1383 E:1391 ||| VB
system  ||| S:1391 E:1398 ||| NN
results ||| S:1398 E:1405 ||| NNS
.  ||| S:1405 E:1407 ||| .
The  ||| S:1407 E:1411 ||| DT
greater  ||| S:1411 E:1419 ||| JJR
resistance  ||| S:1419 E:1430 ||| NN
of  ||| S:1430 E:1433 ||| IN
the  ||| S:1433 E:1437 ||| DT
QF  ||| S:1437 E:1440 ||| NNP
was  ||| S:1440 E:1444 ||| VBD
responsible  ||| S:1444 E:1456 ||| JJ
for  ||| S:1456 E:1460 ||| IN
altered  ||| S:1460 E:1468 ||| JJ
blood  ||| S:1468 E:1474 ||| NN
gases ||| S:1474 E:1479 ||| NNS
,  ||| S:1479 E:1481 ||| ,
respiratory  ||| S:1481 E:1493 ||| JJ
parameters  ||| S:1493 E:1504 ||| NNS
and  ||| S:1504 E:1508 ||| CC
performance  ||| S:1508 E:1520 ||| NN
when  ||| S:1520 E:1525 ||| WRB
compared  ||| S:1525 E:1534 ||| VBN
to  ||| S:1534 E:1537 ||| TO
the  ||| S:1537 E:1541 ||| DT
control  ||| S:1541 E:1549 ||| NN
mask ||| S:1549 E:1553 ||| NN
.  ||| S:1553 E:1555 ||| .
The  ||| S:1555 E:1559 ||| DT
QF  ||| S:1559 E:1562 ||| NNP
system  ||| S:1562 E:1569 ||| NN
reliably  ||| S:1569 E:1578 ||| RB
measured  ||| S:1578 E:1587 ||| VBN
equine  ||| S:1587 E:1594 ||| JJ
pulmonary  ||| S:1594 E:1604 ||| JJ
airflows  ||| S:1604 E:1613 ||| NN
and  ||| S:1613 E:1617 ||| CC
volumes  ||| S:1617 E:1625 ||| NNS
and  ||| S:1625 E:1629 ||| CC
is  ||| S:1629 E:1632 ||| VBZ
suitable  ||| S:1632 E:1641 ||| VBN
for  ||| S:1641 E:1645 ||| IN
research  ||| S:1645 E:1654 ||| NN
and  ||| S:1654 E:1658 ||| CC
clinical  ||| S:1658 E:1667 ||| JJ
use  ||| S:1667 E:1671 ||| NN
provided  ||| S:1671 E:1680 ||| VBD
optimal  ||| S:1680 E:1688 ||| JJ
gas  ||| S:1688 E:1692 ||| NN
exchange  ||| S:1692 E:1701 ||| NN
and  ||| S:1701 E:1705 ||| CC
best  ||| S:1705 E:1710 ||| RBS
possible  ||| S:1710 E:1719 ||| JJ
physical  ||| S:1719 E:1728 ||| JJ
performance  ||| S:1728 E:1740 ||| NN
are  ||| S:1740 E:1744 ||| VBP
not  ||| S:1744 E:1748 ||| RB
required ||| S:1748 E:1756 ||| VBN
.  ||| S:1756 E:1758 ||| .
